NeuroCom International, Inc.

Electronystagmography testing is a diagnostic test used to record spontaneous eye activities. Electronystagmography testing can be used to identify the cause of dizziness, balance dysfunction, and vertigo by testing the vestibular system. Electronystagmography testing is used to detect even the slightest movement of the eyes. The electronystagmography testing is done by using disc electrodes which are attached around the nose and electrical leads of discs electrode are connected to an oscilloscope to measure the spontaneous eye movement. In electronystagmography testing, the movement of the eye is accurately recorded because the cornea is electropositive and retina is electronegative due to which these electrodes accurately record the spontaneous movement of the eye. Videonystagmography test in electronystagmography testing is performed to evaluate eye movements. Calibration test evaluates spontaneous eye movement. The positional test evaluates head position changes and calorie test evaluates eye response to cool air or water and warm air or water placed in the ear canal. For more insights into the Market, Request a Sample of this Report - How Will Global Market Shape Up in Future? The global market for electronystagmography testing is expected to witness high growth over the forecast period. Based on test type, the global electronystagmography testing system market is segmented into Videonystagmography, Rotary Chair Test, Computerized Dynamic Visual Acuity (DVA), Computerized Dynamic Posturography (CDP), Subjective Visual Vertical, and Vestibular Evoked Myogenic Potential (VEMP). Based on indications, the global electronystagmography testing system market is segmented into vertigo, dizziness, balance dysfunction, and involuntary eye movement (Nystagmus). Based on the end user, the market is segmented into hospitals, clinics, diagnostic centers, and others. Electronystagmography testing requires skilled professionals to perform the test. Due to the presence of good physicians and comparatively better availability of skilled professionals, hospitals are preferred for testing compared to clinics and diagnostic centers. The increasing number of inner ear disorders that cause vertigo is likely to boost the demand for electronystagmography testing market. Also, increasing healthcare spending, better infrastructure, and reimbursement facilities are expected to be the major factors driving the growth of the electronystagmography testing market over the forecast period. However, limited awareness about related disorders in the developing nations, the high cost of the tests & devices, and availability of cheap alternatives in the market are expected to be the major restraining factors for the growth of the electronystagmography testing market. View Detailed Table of Content Here: What Drives European Market? Geographically, the global electronystagmography testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America is expected to be dominant in the global electronystagmography testing market owing to lifestyle changes, new product innovations, early treatment adoption, and high health care spending as compared to other regions. Europe is expected to register the second largest share in the global electronystagmography testing market due to development activities, owing to increased awareness and large research base. The electronystagmography testing market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by the key domestic players. The global electronystagmography testing market is highly fragmented owing to the presence of a large number of domestic manufacturers. Examples of some of the key players operating in the global electronystagmography testing market are DIFRA Instrumentation, Interacoustics, Micromedical Technologies, Neurocom International, Neuro Kinetics, Otometrics, SensoMotoric Instruments, Balanceback, BeOn Solutions, BioMed Jena, Recorders & Medicare Systems, Happersberger Otopront GmbH, Interacoustics, and others. Request Methodology on this Research Report for specific research solutions: Explore Fact.MR’s Lucid Healthcare Coverage Drug Discovery Services Market – Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services. Introduction of advanced technology in the drug discovery process is also the major driver in the market growth. Preimplantation Genetic Testing Market – The preimplantation genetic testing market is likely to be influenced by a combination of macroeconomic and microeconomic factors. Due to the changing lifestyle, increasing number of people are suffering from genetic disorders or diseases. Hence there has been a significant demand growth in preimplantation genetic testing. About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. Contact: Sudip Saha US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Corporate Headquarter: Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates